January 19, 2022 – TSC Endovision and Flexicare have announced an exclusive partnership for the distribution of TSC Endovision’s Broncoflex, an innovative single-use bronchoscope, in the US market.
The endoscopy market landscape continues to evolve as regulatory bodies across the globe recommend single-use technology to reduce cross-contamination risk and improve patient outcomes. The latest version of the Broncoflex product range was commercially launched in European markets in 2020. The Broncoflex solution is a fully sterile, cost-effective, ergonomically designed solution, requiring only two sizes that cover all flexible bronchoscopy therapeutic indications. The Parties are thrilled to now also make this innovative technology available to US healthcare providers.
From Luc Van Schil, CEO and founder of TSC, “We are pleased to announce an exclusive partnership with Flexicare for the US market. This collaboration brings together leading-edge endoscopy technology with a high-performing and experienced commercial US organization. This will allow for a promising Broncoflex US market introduction and will support healthcare’s transition to single-use endoscopy.”
With over 2.5 million bronchoscopy procedures performed each year in the US, TSC Endovision and Flexicare are well positioned to bring the Broncoflex to the largest endoscopy market and support acute care physicians with a single-use technology that will meet their flexible bronchoscopy needs.
“The addition of the Broncoflex technology to the Flexicare portfolio further supports our commitment to bring innovative, high-quality technologies that meet and exceed the needs of healthcare professionals and improve patient outcomes. We are proud to partner with TSC Endovision in bringing this next level technology to the US market,” states Ghassem Poormand, CEO and founder of Flexicare.